Abstract
The incidence and mortality of malignant neoplasm of oropharynx is significant in many European countries. Our aim was to determine the annual health insurance treatment cost of malignant neoplasm of oropharynx in Hungary.
Full Text 
Sign-in/Register to access full text options
Sign-in/Register to access full text options 
Published version (
Free)
Free) 
Talk to us
Join us for a 30 min session where you can share your feedback and ask us any queries you have
Schedule a callMore From: Value in health : the journal of the International Society for Pharmacoeconomics and Outcomes Research
Paper Title
Journal
Date
